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carcinomas with oral acitretin combined with excisionDear Editor,A 61-year-old man presented with a 13-year history of multiple
brown plaques all over his body. He had been feeding chickens for
16 years, and was often scratched or pecked in the upper limbs.
Some lesions developed with a deﬁnite history of injury. Others
around him who were feeding chickens did not have similar
skin damage. The patient had suffered from several systemic dis-
eases, such as chronic bronchitis and gastritis, for many years and
took antibiotics and traditional Chinese medicine intermittently.
The patient acknowledged occasional contact with farm chemi-
cals, but denied any contact with coal tar. No source of arsenic
was identiﬁed. Dermatological examination revealed about 40
brown macules and plaques distributed diffusely on his trunk
and extremities (Figure 1A). There was a hard oyster shell-like
nodule on the back of the right thumb. A black neoplasm 2 cm
in diameter with a smooth but uneven surface was found on the
scalp (Figure 2A). The patient’s urine sample was within the
normal limit for arsenic, with a level of 0.676 mg/L. Histopatholog-
ical examination showed that the brown plaque on the left chest
was consistent with Bowen’s disease (Figure 1B), the nodule on
the right thumb was a well-differentiated squamous cell carci-
noma, and the black neoplasm on the scalp was a basal cell carci-
noma (Figure 2B). The squamous cell carcinoma was excised and a
skin graft was done. Other lesions were treated with oral acitretin,
30 mg daily. Vitamin E, 100 mg twice a day, was prescribed to alle-
viate dryness. Most rashes were almost completely eradicated 10Figure 1 Multiple Bowen’s disease. (A) Multiple brunneus macules and plaques distributed
the atypical epidermal keratinocytes show variation in size and staining. However, the bas
almost completely eradicated. (B, hematoxylin-eosin stain; original magniﬁcation 100.)
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graft area. The basal cell carcinoma on the scalp had regressed
by 70% at 6 months after the initiation of treatment (Figure 2C),
but gradually increased in size to 50% of the initial size over the
following 4 months (Figure 2D). The remainder was removed sur-
gically. The treatment regimen was well tolerated by the patient.
The only adverse effect reported was mild dryness of the mouth,
eyes, and skin. The acitretin treatment was discontinued after a
total of 10 months. There has been no recurrence of the resolved
lesions in the 22 months following the discontinuation of therapy.
Multiple Bowen’s disease is usually induced by arsenic inges-
tion, chronic sun damage, or human papillomavirus infection.1e3
In our patient, although no source of arsenic was identiﬁed and
the urine sample was within the normal limits for arsenic, chronic
exposure to arsenic cannot be excluded because hair or nail were
not tested for arsenic. The patient was often scratched or pecked
in the upper limbs during the feeding of chickens, and some lesions
developed with a deﬁnite history of injury. We speculate that
chronic mechanical damage may have contributed to the occur-
rence of multiple Bowen’s disease in our patient, which has seldom
been reported.
Common treatments for multiple Bowen’s disease are excision,
CO2 laser therapy, liquid nitrogen cryotherapy, photodynamic ther-
apy, and topical imiquimod.1e3 These are all localized therapeutic
options. In some cases, retinoid combined with another treatment
has been used.4,5 In our patient, given his poverty and the large
number of lesions, a trial of systemic retinoid alone wasdiffusely on his trunk; (B) the cellular architecture of the epidermis is disorganized and
ement is intact and (C) after 10 months of treatment with acitretin, most rashes were
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Figure 2 Basal cell carcinoma. (A) A black neoplasm on the scalp; (B) basaloid cell clump-like cell mass in the dermis, at the periphery of which are columnar cells; (C) the neoplasm
had regressed by 70% 6 months after the beginning of acitretin treatment; and (D) it gradually increased in size to 50% of the initial size in the following 4 months. (B, hematoxylin-
eosin stain; original magniﬁcation 100.)
Correspondence / Dermatologica Sinica 32 (2014) 189e190190undertaken. Signiﬁcant improvement was observed. For the treat-
ment of patients suffering from multiple Bowen’s disease, our ob-
servations provide an alternative regimen that has many
advantages, such as little pain, low cost, and ease of administration.
We suggest a larger trial of acitretin with long-term follow-up to
verify its efﬁcacy.
There have been reports that the use of retinoids is effective
for the treatment of squamous cell carcinoma.6 Patients at high
risk for the development of cutaneous malignancies, including
patients with xeroderma pigmentosum, psoriasis treated with
psoralen-UVA, and those undergoing organ transplantation,
have developed fewer cutaneous squamous cell carcinomas while
receiving long-term or continuous therapy with retinoids.6,7 Thus,
we speculate that in our patient, oral acitretin may have provided
beneﬁts in preventing a recurrence of squamous cell carcinoma
after surgical excision. This needs to be conﬁrmed by larger,
long-term trials.
It has been reported that combined acitretin and imiquimod
was effective in treating basal cell carcinoma.8 However,
others found that basal cell carcinoma did not respond to iso-
tretinoin and interferon alfa.4 In our patient, given acitretin
alone, the basal cell carcinoma regressed, but did not disap-
pear. Thus, it appears that retinoids may not be as effective
in treating basal cell carcinoma as in treating multiple Bowen’s
disease. Nevertheless, acitretin produced a marked reduction in
the tumor mass in our patient, which facilitated its surgical
excision.
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